News
Press Releases
2019/03/11
WuXi AppTec Testing Facilities Complete Three Regulatory Inspections from US FDA, OECD, and CNAS with Excellent Results
Shanghai, March 11, 2019 – Three of WuXi AppTec Laboratory Testing Division’s facilities, Drug Safety Testing, Bioanalytical Services and Medical Device Testing, recently completed regulatory inspections from the US FDA (Food and Drug Administration), OECD (Organization for Economic Co-operation and Development), and CNAS (China National Accreditation Service for Conformity Assessment), all with excellent results.
Read more2019/03/05
The First WuXi Healthcare Forum opens in Shanghai
Shanghai March 5, 2019 - The first “WuXi Healthcare Forum” opened at the St. Regis Shanghai Jing’an today, gathering together world-class scientists, alongside innovators, entrepreneurs, and investors. The forum attracts application of more than 5,000 industry leaders from 2,000 enterprises and organizations, spanning 20 countries, bring their collective insights to bare on the global challenges facing healthcare – exploring what breakthroughs have been achieved, the present realities and future possibilities.
Read more2019/02/19
WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery
SHANGHAI and SAN DIEGO, February 19, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec – and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing collaboration for sublingual delivery.
Read more2018/12/13
WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange
HONG KONG and SHANGHAI, December 13, 2018-- WuXi AppTec Co., Ltd. (“WuXi AppTec” or “the Company”; Stock code: 603259.SH/2359.HK) today announced the listing of approximately 116 million H-shares on the Main Board of the Hong Kong Stock Exchange. Based on the offer price of HK$68 per share, the net proceeds to be received by the Company are about HK$7,553 million (assuming the Over-allotment Option is not exercised).
Read more2018/12/11
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
SAN DIEGO, CA and SHANGHAI, December 11, 2018 – WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California.
Read more